Galapagos NV (NASDAQ:GLPG)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $52.61, but opened at $53.01. Galapagos NV shares last traded at $53.87, with a volume of 18,387 shares changing hands.

A number of brokerages have commented on GLPG. Zacks Investment Research upgraded shares of Galapagos NV from a “sell” rating to a “hold” rating in a research note on Wednesday, May 4th. Morgan Stanley restated a “buy” rating and issued a $89.00 target price on shares of Galapagos NV in a research note on Monday, May 2nd. Credit Suisse Group AG restated a “hold” rating and issued a $48.00 target price on shares of Galapagos NV in a research note on Friday, June 17th. Finally, Cowen and Company restated a “buy” rating on shares of Galapagos NV in a research note on Saturday, April 30th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of €65.50 ($72.78).

The stock’s 50-day moving average price is $53.91 and its 200-day moving average price is $48.72. The firm’s market cap is $2.47 billion.

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.